Download PDF
Thromb Haemost 1975; 33(02): 286-309
DOI: 10.1055/s-0038-1647882
Original Article
Schattauer GmbH

Plasmin Inhibition of Thrombin-induced Platelet Aggregation[*]

Jonathan L Miller
1   Departments of Pharmacology and Laboratory Medicine, University of Connecticut Health Center, Farmington, Connecticut 06032
,
Alfred J Katz
1   Departments of Pharmacology and Laboratory Medicine, University of Connecticut Health Center, Farmington, Connecticut 06032
,
Maurice B Feinstein
1   Departments of Pharmacology and Laboratory Medicine, University of Connecticut Health Center, Farmington, Connecticut 06032
› Author Affiliations
Further Information

Publication History

Received 06 July 1974

Accepted 25 September 1974

Publication Date:
02 July 2018 (online)

    Permissions and Reprints

Summary

The effects of plasmin treatment upon washed human platelets were studied in an attempt to elucidate the mechanisms underlying thrombin-induced platelet aggregation. At calcium concentrations of 10–20 μM, plasmin (0.2 CTA U/ml) inhibited thrombin-induced aggregation almost completely, but did not diminish the thrombin-induced release of adenine nucleotides, 5-hydroxytryptamine, or calcium. Increasing the calcium concentration partially antagonized plasmin’s inhibition of aggregation.

Studies utilizing calcium chelators and the Kunitz soybean trypsin inhibitor (SBTI) as a plasmin inhibitor indicated that in order to achieve maximal block of aggregation, plasmin must act upon a substrate made fully available only after an initial thrombin-platelet interaction has taken place. Moreover, the time course of this inhibition parallels the time course of the thrombin-induced release reaction.

Plasmin inhibition of aggregation could not be mimicked by exposing the platelets to proteolytic digests of fibrinogen at concentrations as high as 17% total platelet protein. Nor could inhibitory activity be recovered from supernatants of plasmin -treated platelets, upon centrifugation and treatment with SBTI.

With the use of a “cold initiation” technique, the release by thrombin of 46.7 ± 6-7 (mean ± SEM) μg of fibrinogen immunological equivalents per mg platelet protein could be demonstrated. Platelets in which thrombin-induced aggregation was abolished by plasmin treatment (and the plasmin subsequently inactivated by SBTI) aggregated normally upon addition of as little as 10 μg human plasma fibrinogen per mg platelet protein.

It is concluded that plasmin inhibition of aggregation most likely results from its attack upon a protein that is released or becomes fully available subsequent to interaction of thrombin with a platelet receptor mediating release. The results of this study are consistent with a cofactor role for fibrinogen in the aggregation of human platelets by thrombin.

* From a thesis submitted by Dr. J. L. Miller in partial fulfillment of the requirements for the degree of Doctor of Philosophy at the University of Connecticut.

* This work was presented in part at the 57th Annual Meeting of the Federation of American Societies for Experimental Biology, Atlantic City, N. J., April 1973 (Federation Proceedings 32, 289).


 

  • References

  • 1 Aster R. H, Jandl J. H. Platelet sequestration in man. I. Methods. Journal of Clinical Investigation 1964; 43: 843
    PubMedGoogle Scholar
  • 2 Atencio A.C, Bukdick D. C, Reeve E. B. An accurate isotope dilution method for measuring plasma fibrinogen. Journal of Laboratory and Clinical Medicine 1965; 66: 137
    PubMedGoogle Scholar
  • 3 Bagdy D, Barabas E, Graf L. Large scale preparation of hirudin. Thrombosis Research 1973; 2: 229
    CrossrefPubMedGoogle Scholar
  • 4 Bergmeyer H, Bernt E, Hess B. Lactic dehydrogenase. In: Bergmeyer H. (ed.) Methods of Enzymatic Analysis Academic Press; New York: 1965: 736
    Google Scholar
  • 5 Booyse F. M, Rafelson Jr. M. E. Regulation and mechanism of platelet aggregation. Annals of the New York Academy of Sciences 1972; 201: 37
    CrossrefPubMedGoogle Scholar
  • 6 Born G. V. R. Quantitative investigations into the aggregation of blood platelets. Journal of Physiology (London) 1962; 162: 67
    PubMedGoogle Scholar
  • 7 Davey M. G, Lüscher E. F. Actions of some coagulant snake venoms on blood platelets. Nature (London) 1965; 207: 730
    CrossrefPubMedGoogle Scholar
  • 8 Davey M. G, Lüscher E. F. Actions of thrombin and other coagulant and proteolytic enzymes on blood platelets. Nature (London) 1967; 216: 857 a
    CrossrefPubMedGoogle Scholar
  • 9 Davey M. G, Lüscher E. F. Platelet proteins. In: Kowalski E, Niewiarowski S. (eds.) Biochemistry of Blood Platelets Academic Press; New York: 9 1967. b
    Google Scholar
  • 10 Davey M. G, Lüscher E. F. Release reactions of human platelets induced by thrombin and other agents. Biochimica et Biophysica Acta 1968; 165: 490
    CrossrefPubMedGoogle Scholar
  • 11 Day H. J, Ang G. A, Holmsen H. Platelet release reaction during clotting of native human platelet-rich plasma. Proceedings of the Society for Experimental Biology and Medicine 1972; 139: 717
    PubMedGoogle Scholar
  • 12 Detwtller T. C, Feinman R. D. Kinetics of the thrombin-induced release of adenosine triphosphate by platelets. Comparison with release of calcium. Biochemistry 1973; 12: 2462
    PubMedGoogle Scholar
  • 13 Donaldson V. H. Effect of plasmin in vitro on clotting factors in plasma. Journal of Laboratory and Clinical Medicine 1960; 56: 644
    PubMedGoogle Scholar
  • 14 Donati M. B, Degaetano G, Vernylen J. Evidence that bovine factor VIII, not bovine fibrinogen aggregates human platelets. Thrombosis Research 1973; 2: 97
    CrossrefPubMedGoogle Scholar
  • 15 Endres F. G, Scheraga H. A. Equilibria in the fibrinogen-fibrin conversion. IX. Effects of calcium ions on the reversible polymerization of fibrin monomer.. Archives of Biochemistry and Biophysics 1972; 153: 266
    CrossrefPubMedGoogle Scholar
  • 16 Forbes C.D, Prentice C. R.M. Aggregation of human platelets by purified porcine and bovine antihaemophilic factor. Nature New Biology 1973; 241: 149
    CrossrefPubMedGoogle Scholar
  • 17 Ganguly P. Isolation and some properties of fibrinogen from human blood platelets. Journal of Biological Chemistry 1972; 247: 1809
    PubMedGoogle Scholar
  • 18 Gornall A. G, Bardawill C. J, David M. M. Determination of serum proteins by means of the biuret reaction. Journal of Biological Chemistry 1949; 177: 751
    PubMedGoogle Scholar
  • 19 Grette K. The release of 5-hydroxytryptamine (serotonin) from blood platelets during coagulation. Scandinavian Journal of Clinical and Laboratory Investigation 1959; 11: 50
    CrossrefPubMedGoogle Scholar
  • 20 Grette K. Studies on the mechanism of thrombin-catalyzed hemostatic reactions in blood platelets. Acta Physiologica Scandinavica 56 (Suppl. 195) 1 1962;
    CrossrefPubMedGoogle Scholar
  • 21 Holmsen H, Day H. J. The selectivity of the thrombin-induced platelet release reaction: Subcellular localization of released and retained constituents. Journal of Laboratory and Clinical Medicine 1970; 75: 840
    PubMedGoogle Scholar
  • 22 Jerushalmy Z, Skoza L, Zucker M. B, Grant R. Inhibition by guanidino compounds of platelet aggregation induced by adenosine diphosphate. Biochemical Pharmacology 1966; 15: 1791
    CrossrefPubMedGoogle Scholar
  • 23 Jevons S, Barton P. G. Biochemistry of blood platelets. Interaction of activated factor X with platelets. Biochemistry 1971; 10: 428
    PubMedGoogle Scholar
  • 24 Keenan J. P. Platelet fibrinogen. 1. Quantitation using fibrinogen sensitized tanned red cells. Medical Laboratory Technology 1972; 29: 71
    PubMedGoogle Scholar
  • 25 Keenan J. P, Solum N. O. Quantitative studies on the release of platelet fibrinogen by thrombin. British Journal of Haematology 1972; 23: 461
    CrossrefPubMedGoogle Scholar
  • 26 Kline D. L. Caseinolytic techniques. In: Bang N. U, Beller F. K, Deutsch E, Mammen E. F. (eds.) Thrombosis and Bleeding Disorders. Theory and Methods. Academic Press; New York: 358 1971
    Google Scholar
  • 27 Kowalski E, Kopec M, Wegrzynowicz Z. Influence of fibrinogen degradation products (FDP) on platelet aggregation, adhesiveness and viscous metamorphosis. Thrombosis et Diathesis Haemorrhagica 1964; 10: 406
    PubMedGoogle Scholar
  • 28 Lewis J. H. Hemorrhagic disease associated with inhibitors of fibrin cross-linkage. Annals of the New York Academy of Sciences 1972; 202: 213
    CrossrefPubMedGoogle Scholar
  • 29 Lorand L. Fibrinoligase : The fibrin-stabilizing factor system of blood plasma. Annals of the New York Academy of Sciences 1972; 202: 6
    CrossrefPubMedGoogle Scholar
  • 30 McDonagh J, McDonagh R. P. Factor XIII from human platelets; effect on fibrin crosslinking. Thrombosis Research 1972; 1: 147
    CrossrefPubMedGoogle Scholar
  • 31 McDonagh J, Wagner R. H. Site of synthesis of plasma and platelet factor XIII. Annals of the New York Academy of Sciences 1972; 202: 31
    CrossrefPubMedGoogle Scholar
  • 32 Merskey C, Kleiner J, Johnson A. J. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood 1966; 28: 1
    PubMedGoogle Scholar
  • 33 Morse E. E, Jackson D. P, Conley C. L. Role of platelet fibrinogen in the reactions of platelets to thrombin. Journal of Clinical Investigation 1965; 44: 809
    CrossrefPubMedGoogle Scholar
  • 34 Mürer E. H. Release reaction and energy metabolism in blood platelets with special reference to the burst in oxygen uptake. Biochimica et Biophysica Acta 1968; 162: 320
    CrossrefPubMedGoogle Scholar
  • 35 Mürer E. H. Factors influencing the initiation and the extrusion phase of the platelet release reaction. Biochimica et Biophysica Acta 1972; 261: 435
    CrossrefPubMedGoogle Scholar
  • 36 Mustard J. F, Packham M. A. Factors influencing platelet function: adhesion, release, and aggregation. Pharmacological Reviews 1970; 22: 97
    PubMedGoogle Scholar
  • 37 Mustard J. F, Perry D. W, Ardlie N. G, Packham M. A. Preparation of suspensions of washed platelets from humans. British Journal of Haematology 1972; 22: 193
    CrossrefPubMedGoogle Scholar
  • 38 Nachman R. L, Marcus A. J, Zucker-Franklin D. Immunologic studies of proteins associated with subcellular fractions of normal human platelets. Journal of Laboratory and Clinical Medicine 1967; 69: 651
    PubMedGoogle Scholar
  • 39 Niewiarowski S, Gurewich V, Senyi A. F, Mustard J. F. The effect of fibrinolysis on platelet function. Thrombosis et Diathesis Haemorrhagica Supplement 1971; 47: 99
    PubMedGoogle Scholar
  • 40 Niewiarowski S, Regoeczi E, Mustard J. F. Platelet interaction with fibrinogen and fibrin: comparison of the interaction of platelets with that of fibroblasts, leukocytes, and erythrocytes. Annals of the New York Academy of Sciences 1972; 201: 72
    CrossrefPubMedGoogle Scholar
  • 41 Niewiarowski S, Senyi A. F, Gillies P. Plasmin-induced platelet aggregation and platelet release reaction. Effects on hemostasis. Journal of Clinical Investigation 52: 1647 1973;
    PubMedGoogle Scholar
  • 42 Ohnishi T, Ebashi S. Spectrophotometric measurement of instantaneous calcium binding of the relaxing factor of muscle. Journal of Biological Chemistry (Tokyo) 1963; 54: 506
    PubMedGoogle Scholar
  • 43 Pasquini R, Hershgold E. J. Effects of plasmin on human factor VIII (AHF). Blood 1973; 41: 105
    PubMedGoogle Scholar
  • 44 Phillips D. R. Effect of trypsin on the exposed polypeptides and glycoproteins in the human platelet membrane. Biochemistry 1972; 11: 4582
    CrossrefPubMedGoogle Scholar
  • 45 Rodman Jr. N. F, Mason B. G, Painter J. C, Brinkhous K. M. Fibrinogen — its role in platelet agglutination and agglutinate stability. Laboratory Investigation 1966; 15: 641
    PubMedGoogle Scholar
  • 46 Salzman E. W, Chambers D. A. Inhibition of ADP-induced platelet aggregation by substituted amino acids. Nature (London) 1964; 204: 698
    PubMedGoogle Scholar
  • 47 Solum N. O. ADP-induced aggregation of washed platelets. Effect of platelet and plasma fibrinogen. Scandinavian Journal of Haematology 7: 236 1970;
    PubMedGoogle Scholar
  • 48 Solum N. O, Lopaciuk S. Bovine platelet proteins. II. Purification of platelet fibrinogen. Thrombosis et Diathesis Haemorrhagica 1969; a 21: 419
    PubMedGoogle Scholar
  • 49 Solum N. O, Lopaciuk S. Bovine platelet proteins. III. Some properties of platelet fibrinogen.. Thrombosis et Diathesis Haemorrhagica 1969; b 31: 428
    PubMedGoogle Scholar
  • 50 Takeda Y. Studies of the metabolism and distribution of fibrinogen in healthy men with autologous 125I-labeled fibrinogen. Journal of Clinical Investigation 1966; 45: 103
    CrossrefPubMedGoogle Scholar
  • 51 Van Mouriez J. A, Mochtar I. A. Purification of human antihemophilic factor (factor VIII) by gel chromatography. Biochimica et Biophysica Acta 1970; 221: 677
    CrossrefPubMedGoogle Scholar
  • 52 Vermylen J, Donati M. B, De Gaetano D, Verstraete M. Aggregation of human platelets by bovine or human factor VIII : Role of carbohydrate side chains. Nature 1973; 244: 167
    CrossrefPubMedGoogle Scholar
  • 53 Weiss H. J, Rogers J, Brand H. Defective ristocetin-induced platelet aggregation in von Willebrand’s disease and its correction by factor VIII. Journal of Clinical Investigation 1973; 52: 2697
    CrossrefPubMedGoogle Scholar
  • 54 Weissbach H, Waalkes T. P, Udenfriend S. A simplified method for measuring serotonin in tissues, simultaneous assay of both serotonin and histamine. Journal of Biological Chemistry 1958; 230: 865
    PubMedGoogle Scholar
  • 55 Yin E. G, Giudice C, Wessler S. Inhibition of activated factor X-induced platelet aggregation : the role of heparin and the plasma inhibitor to activated factor X. Journal of Laboratory and Clinical Medicine 1973; 82: 390
    PubMedGoogle Scholar